Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


Agchem innovation recognised by Callaghan

25 June 2014

Agchem innovation recognised by Callaghan

A major investment in technology by Zelam Limited, a New Plymouth-based agrichemical company, has been recognised by Callaghan Innovation.

Zelam is well-known on the land for its popular agrichemical brands – like TAG G2, Headstart, Pycus and Vixen. But few farmers and growers will be aware that the company behind these brands has one of the country’s largest research teams outside the universities and CRIs.

Each year, Zelam invests up to $3 million in chemistry, field trials and analyses. Now 20 per cent of its New Zealand research budget is being refunded by way of R&D grants from Callaghan Innovation, a government agency that helps fund businesses that invest in research and development.

The aim of the grants is to accelerate innovation by firms in New Zealand, so they turn ideas into marketable products and services more quickly and successfully.

“Of our 45 staff, 17 are full-time researchers,” says general manager Andrew Thompson.

“Our research focus is on tried and true agrichemicals that are off-patent. By developing novel formulations and delivery mechanisms for these products, we are helping farmers to beat weeds, pest and diseases that continue to prevent crops reaching full yield potential.

“We have developed formulations that are effective at lower application rates than established products. In addition, our oleo formulations make it easier for farmers by providing a one-drum product, versus having to mix separate products that are not normally stable in water.”

Of the company’s 10 top selling products, eight are based on Zelam IP. These include innovative mixes of chemical actives, the use of micro-encapsulation technology developed by Zelam and the adaptation through trial work in New Zealand of actives used in unrelated crops overseas.

Some of Zelam’s formulations have a big potential to earn foreign exchange from sales overseas. But most of the company’s products will reward taxpayer support indirectly – by making farmers and growers more efficient and helping boost the primary export economy.

Research manager Paul Lobb says the Callaghan funding is very welcome.

“Over the next five years we expect to get Callaghan grants of up to $3 million, which gives a good indication of the investment we are making in new technology. This will enable us to increase our investment in R&D by a similar amount.”

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Media: Julian Wilcox Leaves Māori TV

Māori Television has confirmed the resignation of Head of News and Production Julian Wilcox. Mr Maxwell acknowledged Mr Wilcox’s significant contribution to Māori Television since joining the organisation in 2004. More>>

ALSO:

Genetics: New Heat Tolerant Cow Developed

Hamilton, New Zealand-based Dairy Solutionz Ltd has led an expert genetics team to develop a new dairy cow breed conditioned to thrive in lower elevation tropical climates and achieve high milk production under heat stress. More>>

Fractals: Thousands More Business Cards Needed To Build Giant Sponge

New Zealand is taking part in a global event this weekend to build a Menger Sponge using 15 million business cards but local organisers say they are thousands of business cards short. More>>

Scoop Business: NZ Net Migration Rises To Annual Record In September

New Zealand’s annual net migration rose to a record in September, beating government forecasts, as the inflow was spurred by student arrivals from India and Kiwis returning home from Australia. More>>

ALSO:

Scoop Business: Fletcher To Close Its Christchurch Insulation Plant, Cut 29 Jobs

Fletcher Building, New Zealand’s largest listed company, will close its Christchurch insulation factory, as it consolidates its Tasman Insulations operations in a “highly competitive market”. More>>

ALSO:

Scoop Business: Novartis Adds Nine New Treatments Under Pharmac Deal

Novartis New Zealand, the local unit of the global pharmaceuticals firm, has added nine new treatments in a far-ranging agreement with government drug buying agency, Pharmac. More>>

ALSO:

Crown Accounts: English Wary On Tax Take, Could Threaten Surplus

Finance Minister Bill English is warning the tax take may come in below forecast in the current financial year, as figures released today confirm it was short by nearly $1 billion in the year to June 30 and English warned of the potential impact of slumping receipts from agricultural exports. More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand

Mosh Social Media
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news